Source: GlobeNewswire

Press Release: Recro Pharma : Societal CDMO Reports Inducement Grants for New Staff

SAN DIEGO and GAINESVILLE, Ga., July 07, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. ("Societal CDMO"; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced the addition of new employees to fill open roles throughout the organization.

Read full article »
Annual Revenue
$25-100M
Employees
250-500
Gerri Henwood's photo - President & CEO of Recro Pharma

President & CEO

Gerri Henwood

CEO Approval Rating

94/100

Read more